Groundbreaking Treatment For Neuropathy & Other Diabetic Complications
What Is Physiologic Insulin Resensitization?
Physiologic Insulin Resensitization is a groundbreaking multi-patented approach where insulin is administered as a hormone rather than a drug, addressing the primary cause of diabetes, being metabolic failure. By using insulin in a manner that bio-mimics normal physiology, we are better able to reduce insulin resistance, which helps blood sugar more readily enter each cell and be converted into energy.
Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. In many cases, this approach has shown the ability to stabilize, and in some instances reverse, complications of diabetes and other metabolic disorders.
Diabetes Complications
Improvements Reported
95%
Neuropathy
Improved
76%
Improvement in at least one compliaction
63%
HbA1c
Reduction
41%
Medications
Reduction
Schull Institute – Insulin Infusion Therapy on Diabetic Complications (2015)
Typical Care Plan
Every patient’s degree of insulin resistance and efficiency of carbohydrate metabolism is unique; so we begin with a consultation to determine medical necessity and establish a physician-directed, individualized care plan.
Each patient’s unique care plan typically includes an “Induction Phase” of 2 infusions per week and reducing to 1 per week for about 90 days, and a “Maintenance Phase” focused on finding the balance between an optimized metabolism and insulin sensitivity while extending as much time as possible between treatments.
Typically, our Type 2 Diabetic, Prediabetic, and Nondiabetic patients reduce from 3-hour infusions to 2-hour and achieve four to six weeks between infusions while maintaining optimized metabolism and insulin sensitivity.